| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1202975B1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1603313A Method for separation purification of polyhydroxy-alkyl-pyrazine from suger amine reaction liquid |
| 04/06/2005 | CN1195783C Polymerization of olefins |
| 04/06/2005 | CN1195734C Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
| 04/05/2005 | US6875877 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides |
| 04/05/2005 | US6875831 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 04/05/2005 | US6875768 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same |
| 04/05/2005 | US6875764 Urea and thiourea compounds useful for treatment of coccidiosis |
| 04/05/2005 | CA2141209C Novel pyridyl- and pyrimidylpiperazine derivatives |
| 03/31/2005 | WO2005028451A1 Tetrahydroquinoxalines and their use as m2 acetylcholine receptor agonists |
| 03/31/2005 | WO2005028429A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 03/31/2005 | WO2004108133A3 Modulators of vr1 receptor |
| 03/31/2005 | US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders |
| 03/31/2005 | US20050070527 For leukocyte recruitment inhibition, treating or preventing inflammation and H4 receptor-mediated conditions |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | CA2537916A1 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds |
| 03/31/2005 | CA2521811A1 Haloalkyl containing compounds as cysteine protease inhibitors |
| 03/30/2005 | EP1517908A2 Novel benzimidazole derivatives |
| 03/30/2005 | EP1517898A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 03/30/2005 | EP1517896A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 03/30/2005 | EP1517882A1 Amide linker peroxisome proliferator activated receptor modulators |
| 03/30/2005 | EP1444197B1 Novel phenyl-propargylether derivatives |
| 03/30/2005 | EP0877740B1 Thiol derivatives with metallopeptidase inhibitory activity |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1600780A Hypocrellin in cyclic ethylene diamine group, preparation method and usage |
| 03/30/2005 | CN1194969C Iridium catatlyzed enantiotropic hydrosubstituting process of aromatic pyridine ring and pyrazine ring |
| 03/29/2005 | US6872826 Reacting protected heterocyclic amines in the presence of bases and solvents, to form chemical intermeadiates used as chemokine receptor antagonists |
| 03/29/2005 | US6872699 Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein |
| 03/29/2005 | US6872381 Such as 1-(5-chloro-2-(2-((2R)-4-(4-fluoro-18F-benzyl)-2-methylpiperazin-1-yl)-2 -oxoethoxy)phenyl)urea for binding chemokine receptors in brain tissue; tomography |
| 03/24/2005 | WO2005025496A2 Aliphatic pyrazinoylguanidine sodium channel blockers |
| 03/24/2005 | WO2005011657A3 Piperazine derivatives and their use as therapeutic agents |
| 03/24/2005 | WO2005003101A3 Pyrazine and pyridine derivatives as rho kinase inhibitors |
| 03/24/2005 | WO2004085384A8 Bis-aryl sulfonamides |
| 03/24/2005 | WO2004073619A3 Ccr8 antagonists |
| 03/24/2005 | US20050065342 For example, 2,2', 3,3'-tetra(4-(diphenylamino)-phenyl)-6,6'-bisquinoxaline; having a bipolar property and a light emitting property, heat resistance; for electronic devices selected from display devices, cameras, laptop personal computers |
| 03/24/2005 | US20050065095 Antibacterial agents |
| 03/24/2005 | CA2538410A1 2-pyridone derivatives as netrophil elastase inhibitors and their use |
| 03/23/2005 | EP1516877A1 Amine derivatives as protease inhibitors |
| 03/23/2005 | EP1516875A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/23/2005 | EP1516874A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/23/2005 | EP1515956A1 Peptide deformylase inhibitors |
| 03/23/2005 | EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 03/23/2005 | EP1515950A1 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays |
| 03/23/2005 | EP1515944A1 Aspartyl protease inhibitors |
| 03/23/2005 | CN1599611A Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/22/2005 | US6869943 Sorbitol dehydrogenase inhibitors |
| 03/22/2005 | US6869699 A dihydrophenazine compound, and an aromatic tetranitrile compound as dopant used as p-type material |
| 03/17/2005 | WO2005023261A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | WO2005023204A2 Aromatic prodrugs of propofol, compositions and uses thereof |
| 03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
| 03/17/2005 | US20050059676 Cyclic pyrazinoylguanidine sodium channel blockers |
| 03/17/2005 | US20050059668 Substituted acylpiperazine derivatives |
| 03/17/2005 | CA2538135A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/16/2005 | EP1513822A2 Sulfoderivatives of indanthrone, lyotropic liquid crystal system and anisotropic film on their base |
| 03/16/2005 | EP1513821A1 Protein kinase inhibitors |
| 03/16/2005 | EP1513802A1 Alpha-sulfonylamino-acetonitriles |
| 03/16/2005 | EP1513795A2 Propionic acid derivatives and their use as hppars activators |
| 03/16/2005 | EP1115758B1 Polymerization of olefins |
| 03/16/2005 | EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 03/16/2005 | CN1596246A Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds |
| 03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
| 03/16/2005 | CN1594320A Process for preparing L-ofloxacin and ofloxacin |
| 03/16/2005 | CN1193010C Heterocyclonitrogen heteroethane derivant with antiviral activity |
| 03/15/2005 | US6867210 For treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis, acute or chronic pain, as antitinnitus agents, anticonvulsants, antimanic depressants, local anesthetics, antiarrhythmics |
| 03/15/2005 | US6867203 Cinnamide derivatives with aryl sulfide functionality; cerebral vasospasm |
| 03/15/2005 | CA2063671C Aminoguanidines |
| 03/10/2005 | WO2005021547A2 Heterocyclic cannabinoid cb2 receptor antagonists |
| 03/10/2005 | WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors |
| 03/10/2005 | WO2005021513A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases |
| 03/10/2005 | WO2005021512A1 Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
| 03/10/2005 | WO2005021486A1 Ester derivative and medicinal use thereof |
| 03/10/2005 | WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/10/2005 | US20050054732 Preventives or remidies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds |
| 03/10/2005 | US20050054715 Vinyl phenyl derivatives as glk activators |
| 03/10/2005 | US20050054668 Antagonists of MCP-1 function and methods of use thereof |
| 03/10/2005 | US20050054659 Pyrazine modulators of cannabinoid receptors |
| 03/10/2005 | US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders |
| 03/10/2005 | US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 03/10/2005 | US20050054582 Para-amino benzoic acids as integrin antagonists |
| 03/10/2005 | CA2537123A1 New compounds |
| 03/10/2005 | CA2535366A1 Cathepsin inhibitors |
| 03/10/2005 | CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/09/2005 | EP1511742A1 Kinase inhibitors |
| 03/09/2005 | EP1511488A2 Human adam-10 inhibitors |
| 03/09/2005 | EP1018008B1 Method of identification of leads or active compounds |
| 03/09/2005 | CN1592735A Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |
| 03/09/2005 | CN1590378A Quinoxaline derivative and its preparation method and use |
| 03/09/2005 | CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 03/09/2005 | CN1192014C Method for prepring HIV protease inhibitor |
| 03/08/2005 | US6864392 α-Sulfin and α-Sulfonamino amide derivatives |
| 03/08/2005 | US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 03/08/2005 | US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 03/08/2005 | US6863838 Low melting point |
| 03/03/2005 | WO2005019194A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 03/03/2005 | WO2005019188A1 Fused pyrimidine derivative and use thereof |
| 03/03/2005 | WO2005018644A1 Capped pyrazinoylguanidine sodium channel blockers |
| 03/03/2005 | WO2005018531A2 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof |